Prostate-specific antigen, also known as hK3, and its molecular forms are the most useful tumour markers for the prostate cancer and hK2, another member of the kallikrein gene family, may help in reducing the number of unnecessary biopsies (Rittenhouse et al, 1998). The gene discussed is KLK3; the disease is prostate carcinoma.